Everence Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Sell |
6,210
-5,700
| -48% | -$497K | 0.03% | 350 |
|
|
2025
Q1 | $813K | Buy |
11,910
+380
| +3% | +$25.9K | 0.06% | 264 |
|
|
2024
Q4 | $897K | Sell |
11,530
-8,940
| -44% | -$696K | 0.06% | 248 |
|
|
2024
Q3 | $1.37M | Buy |
20,470
+14,800
| +261% | +$992K | 0.09% | 177 |
|
|
2024
Q2 | $722 | Hold |
5,670
| – | – | 0.05% | 284 |
|
|
2024
Q1 | $786 | Hold |
5,670
| – | – | 0.05% | 277 |
|
|
2023
Q4 | $704K | Sell |
5,670
-3,900
| -41% | -$484K | 0.05% | 299 |
|
|
2023
Q3 | $893 | Hold |
9,570
| – | – | 0.07% | 240 |
|
|
2023
Q2 | $1.12M | Hold |
9,570
| – | – | 0.09% | 191 |
|
|
2023
Q1 | $1.11K | Hold |
9,570
| – | – | 0.09% | 196 |
|
|
2022
Q4 | $1.08K | Buy |
9,570
+5,130
| +116% | +$581 | 0.09% | 187 |
|
|
2022
Q3 | $358K | Sell |
4,440
-14,830
| -77% | -$1.2M | 0.03% | 454 |
|
|
2022
Q2 | $1.44M | Buy |
19,270
+8,270
| +75% | +$616K | 0.13% | 144 |
|
|
2022
Q1 | $1.41M | Hold |
11,000
| – | – | 0.11% | 154 |
|
|
2021
Q4 | $1.48M | Hold |
11,000
| – | – | 0.11% | 161 |
|
|
2021
Q3 | $1.5M | Hold |
11,000
| – | – | 0.12% | 144 |
|
|
2021
Q2 | $1.17M | Hold |
11,000
| – | – | 0.1% | 180 |
|
|
2021
Q1 | $988K | Hold |
11,000
| – | – | 0.09% | 189 |
|
|
2020
Q4 | $1.02M | Buy |
11,000
+3,240
| +42% | +$300K | 0.1% | 168 |
|
|
2020
Q3 | $800K | Buy |
+7,760
| New | +$800K | 0.09% | 187 |
|